Why I-MAB's Stock Is Trading Higher Today

I-MAB IMAB shares are trading higher after the company showcased early data on Uliledlimab/Atezolizumab combination in advanced cancer settings.

I-Mab's stock has been rising Thursday, up 10.59% to a price of $70.23. The stock's volume is currently 975.26 thousand, which is roughly 216.68% of its recent 30-day volume average of 450.10 thousand.

The 50-day moving average price of I-MAB's stock was $55.66 when this article was published. The stock reached a high of $67.9 and a low of $20.0 in the past 52 weeks.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.